- Gastroenterology Advisor

Cholangitis

CHOLANGITIS

Feature

Latest News

Liraglutide Increases Risk for Gallbladder, Biliary Tract Events

The researchers observed an increased risk for acute gallbladder or biliary disease with liraglutide versus placebo (hazard ratio, 1.60). Similar findings were seen for each of the four categories of gallbladder- or biliary tract-related events (uncomplicated gallbladder stones, complicated gallbladder stones, cholecystitis with/without gallbladder stones, and biliary obstruction).